NRT Smoking Cessation Aids - Algeria

Date: March 22, 2010
Pages: 21
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: N90A98D8D25EN
Leaflet:

Download PDF Leaflet

In 2009, studies indicated that out of a total population of 33 million, 6.7 million Algerians smoked. In 2008, it was also estimated that 15,000 Algerians die every year from smoking-related diseases. Further studies also indicate that smoking is likely to be the principal cause of death by 2030 if antismoking laws are not enforced correctly. However, despite this high smoking prevalence and dramatic forecasts, NRT smoking cessation aids sales remained negligible in Algeria in 2009. One of the...

Euromonitor International's NRT Smoking Cessation Aids Products in Algeria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Nrt Smoking Cessation Aids in Algeria
Euromonitor International
March 2010

LIST OF CONTENTS AND TABLES

Executive Summary
Consumer Healthcare Products: Regular Growth, Albeit Small
Ban on Imported Products To Boost Local Production
Saidal Algérie SpA Remains Leader in High-value Categories
Chemists/pharmacies Continues To Monopolise Distribution; Problems Persist
Ban on Imported Products To Negatively Affect Growth
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Consumer Health Company Shares by Value 2005-2009
  Table 6 Consumer Health Brand Shares by Value 2006-2009
  Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Definitions
Analgesics
Cough, Cold and Allergy (hay Fever) Remedies
Digestive Remedies
Medicated Skin Care
Nrt Smoking Cessation Aids
Eye Care
Ear Care
Adult Mouth Care
Calming and Sleeping Products
Wound Treatments
OTC Obesity
Emergency Contraception
OTC Statins
OTC Triptans
Vitamins and Dietary Supplements
Slimming Products
Sports Nutrition Products
Herbal/traditional Products
  Summary 1 Research Sources
Biopharm Algérie SpA
Strategic Direction
Key Facts
  Summary 2 Biopharm Algérie SPA: Key Facts
  Summary 3 Biopharm Algérie SPA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 4 Biopharm Algérie SPA: Competitive Position 2009
Saidal Algerie SpA
Strategic Direction
Key Facts
  Summary 5 SAIDAL: Key Facts
  Summary 6 Saidal Algerie SPA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 7 Saidal Algerie Spa: Competitive Position 2009
Societe Pharmaceutique Sophal Sarl
Strategic Direction
Key Facts
  Summary 8 Société Pharmaceutique Sophal SARL: Key Facts
  Summary 9 Société Pharmaceutique Sophal SARL: Operational Indicators
Company Background
Production
Competitive Positioning
Trends
Switches
Skip to top


NRT Smoking Cessation Aids in Germany US$ 990.00 Sep, 2016 · 22 pages
NRT Smoking Cessation Aids in Greece US$ 990.00 Sep, 2016 · 23 pages
NRT Smoking Cessation Aids - Guatemala US$ 900.00 May, 2010 · 22 pages
NRT Smoking Cessation Aids in India US$ 990.00 Sep, 2016 · 24 pages
NRT Smoking Cessation Aids in Italy US$ 990.00 Sep, 2016 · 21 pages

Ask Your Question

NRT Smoking Cessation Aids - Algeria
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: